Literature DB >> 10354265

Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process?

C Y Lu1, J G Penfield, M L Kielar, M A Vazquez, D R Jeyarajah.   

Abstract

Allograft rejection can be caused by numerous factors such as damage to the donor kidney during surgical removal or implantation, injury sustained during the transport process between the donor and recipient, and suboptimal allograft perfusion during the intra- and post-operative period. In cadaveric allografts, damage can occur during cold storage, during the transit stage between donor and recipient, and hemodynamic instability due to the initial damage that caused its removal from the donor (such as brain death or trauma). We hypothesize that rejection requires recognition of this injury in addition to recognition of alloantigens. If indeed injury proves to be one factor in acute rejection episodes, then therapeutic efforts can be made to reduce injury during the transplantation process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354265     DOI: 10.1046/j.1523-1755.1999.00491.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes.

Authors:  Yingyos Avihingsanon; Naili Ma; Martha Pavlakis; W James Chon; Marc E Uknis; Anthony P Monaco; Christiane Ferran; Isaac Stillman; Asher D Schachter; Christina Mottley; Xin Xiao Zheng; Terry B Strom
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

2.  Hyperbaric oxygen therapy and liver transplantation.

Authors:  Vijayaragavan Muralidharan; Chris Christophi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 3.  Marked variation in the definition and diagnosis of delayed graft function: a systematic review.

Authors:  Sri G Yarlagadda; Steven G Coca; Amit X Garg; Mona Doshi; Emilio Poggio; Richard J Marcus; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2008-04-11       Impact factor: 5.992

4.  Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.

Authors:  W Kelly Wu; Olusegun Famure; Yanhong Li; S Joseph Kim
Journal:  Kidney Int       Date:  2015-06-24       Impact factor: 10.612

5.  Pure versus hand-assisted retroperitoneoscopic live donor nephrectomy: a retrospective cohort study of 1508 transplants from two centers.

Authors:  Hiroshi Noguchi; Yoichi Kakuta; Masayoshi Okumi; Kazuya Omoto; Yasuhiro Okabe; Hideki Ishida; Masafumi Nakamura; Kazunari Tanabe
Journal:  Surg Endosc       Date:  2019-03-19       Impact factor: 4.584

6.  Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury.

Authors:  Chihiro Shingu; Hironori Koga; Satoshi Hagiwara; Shigekiyo Matsumoto; Koji Goto; Isao Yokoi; Takayuki Noguchi
Journal:  J Anesth       Date:  2010-05-18       Impact factor: 2.078

Review 7.  Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules.

Authors:  Christopher Y Lu; Pamela D Winterberg; Jianlin Chen; John R Hartono
Journal:  Pediatr Nephrol       Date:  2011-10-28       Impact factor: 3.714

Review 8.  Delayed graft function in the kidney transplant.

Authors:  A Siedlecki; W Irish; D C Brennan
Journal:  Am J Transplant       Date:  2011-09-19       Impact factor: 8.086

9.  IRF-1 promotes inflammation early after ischemic acute kidney injury.

Authors:  Yanxia Wang; Reji John; Jianlin Chen; James A Richardson; John M Shelton; Michael Bennett; Xin J Zhou; Glenn T Nagami; Ying Zhang; Qing Qing Wu; Christopher Y Lu
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

10.  Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.

Authors:  Julian R Pratt; Miriam E Jones; Jun Dong; Wuding Zhou; Paramit Chowdhury; Richard A G Smith; Steven H Sacks
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.